Clinical Trial Update: Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of lapatinib and liposomal doxorubicin for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Lapatinib (Lapatinib)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED